The Effects of Type 2 Diabetes on Lipoprotein Composition and Arterial Stiffness in Male Youth
- Scott M. Gordon1,
- W. Sean Davidson1,
- Elaine M. Urbina2,
- Lawrence M. Dolan3,
- Anna Heink3,
- Huaiyu Zang4,
- L. Jason Lu4 and
- Amy S. Shah3⇑
- 1Department of Pathology, University of Cincinnati College of Medicine, Cincinnati, Ohio
- 2Division of Cardiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
- 3Division of Endocrinology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
- 4Division of Biomedical Informatics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
- Corresponding author: Amy S. Shah, .
Recent studies suggest HDL exists as numerous subpopulations with distinct protein/lipid compositions that are not reflected in the HDL cholesterol (HDL-C) number. In this study, we sought to evaluate HDL subpopulations in adolescents with type 2 diabetes (T2D) to determine if changes in HDL composition are associated with early vascular disease. T2D (n = 10), lean (n = 9), and obese (n = 11) youth were recruited. Plasma was fractionated using gel-filtration chromatography, and lipid-associated proteins were identified using mass spectrometry. Concurrently, vascular stiffness was assessed using pulse wave velocity (PWV). We found youth with T2D exhibited decreased phospholipid content in fractions containing large HDL particles that was inversely associated with PWV (P < 0.001). No association was noted between HDL-C and PWV. Proteomic analysis revealed changes in 7 of 45 identified proteins in the T2D group, including apolipoprotein (apo) A-II, apoE, and paraoxonase-1 (P < 0.05). Our data demonstrate early changes in the lipid and protein compositions of specific HDL subspecies in adolescents with T2D that are related to early markers of arterial disease. These findings suggest that analyzing the composition of HDL, rather than HDL-C, may be useful in assessing cardiovascular risk in this population.
This article contains Supplementary Data online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db12-1753/-/DC1.
See accompanying commentary, p. 2662.
- Received December 13, 2012.
- Accepted April 15, 2013.
- © 2013 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.